ODDB.org: Open Drug Database

Hasten Biopharmaceutic (Switzerland) AG - Hanarbe 20 mg, Tabletten

Swissmedic Registration	69936	Sequence	01
Product name	Hanarbe 20 mg	Description	Tabletten
ATC-Classification	C09CA09	ATC-Description	Azilsartan Medoxomil
Introduction of Sequence	08.08.2024

Composition

azilsartanum medoxomilum 20 mg ut azilsartanum medoxomilum kalicum 21.34 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 0.80 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Azilsartanum Medoxomilum	20 mg

Inactive agents	Dose
Acidum Fumaricum
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Hydroxypropylcellulosum
Magnesii Stearas
Mannitol
Sodium Hydroxide
Sodium	0.8 mg
Pro Compresso

Package number	Package Size	EFP	CP	Category	Out of trade (MedRef)
001	28	PR	PR	B	No
002	98	PR	PR	B	No
003	14	PR	PR	B	No

2025	©ywesee GmbH